Drug Enforcement Administration December 2017 – Federal Register Recent Federal Regulation Documents

Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC
Document Number: 2017-28178
Type: Notice
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Document Number: 2017-28177
Type: Notice
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: ABBVIE LTD; Correction
Document Number: 2017-28176
Type: Notice
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) published a document in the Federal Register of December 1, 2017, concerning a notice of application that inadvertently misstated what the firm plans to do with imported tapentadol.
Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I
Document Number: 2017-28114
Type: Proposed Rule
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is publishing this notice of intent to issue an order temporarily scheduling fentanyl-related substances that are not currently listed in any schedule of the Controlled Substances Act (CSA). The temporary order will place these substances in schedule I. This action is based on a finding by the Administrator that the placement of these synthetic opioids in schedule I is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose regulatory requirements under the CSA on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of these synthetic opioids, as well as administrative, civil, and criminal remedies with respect to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2017-27512
Type: Notice
Date: 2017-12-21
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration as bulk manufacturers of various classes of schedule I and II controlled substances.
Michel P. Toret, M.D.; Decision and Order
Document Number: 2017-27186
Type: Notice
Date: 2017-12-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: VHG Labs DBA LGC Standard Warehouse
Document Number: 2017-26855
Type: Notice
Date: 2017-12-13
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-Related Substances in Schedule I
Document Number: 2017-26854
Type: Proposed Rule
Date: 2017-12-13
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule seven fentanyl-related substances in schedule I. These seven substances are: N-(1-phenethylpiperidin-4-yl)- N-phenylpentanamide (valeryl fentanyl), N-(4-fluorophenyl)- N-(1-phenethylpiperidin- 4-yl)butyramide (para-fluorobutyryl fentanyl), N-(4-methoxyphenyl)- N-(1- phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl), N- (4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl)isobutyramide (para- chloroisobutyryl fentanyl), N-(1-phenethylpiperidin- 4-yl)-N- phenylisobutyramide (isobutyryl fentanyl), N-(1-phenethylpiperidin-4- yl)- N-phenylcyclopentane carboxamide (cyclopentyl fentanyl), and N-(2- fluorophenyl)- 2-methoxy-N-(1-phenethylpiperidin- 4-yl)acetamide (ocfentanil). This action is based on a finding by the Administrator that the placement of these seven synthetic opioids in schedule I of the Controlled Substances Act (CSA) is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I controlled substances under the CSA on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of these synthetic opioids.
Schedules of Controlled Substances: Placement of MT-45 Into Schedule I
Document Number: 2017-26853
Type: Rule
Date: 2017-12-13
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final order, the Administrator of the Drug Enforcement Administration places the substance MT-45 (Systematic IUPAC Name: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), including its salts, isomers, and salts of isomers into schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act and is required in order for the United States to discharge its obligations under the Single Convention on Narcotic Drugs, 1961. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, MT-45.
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceutical, Inc.
Document Number: 2017-26507
Type: Notice
Date: 2017-12-08
Agency: Drug Enforcement Administration, Department of Justice
Kofi E. Shaw-Taylor, M.D. Decision and Order
Document Number: 2017-25922
Type: Notice
Date: 2017-12-01
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: ABBVIE LTD
Document Number: 2017-25921
Type: Notice
Date: 2017-12-01
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Nanosyn, Inc.
Document Number: 2017-25916
Type: Notice
Date: 2017-12-01
Agency: Drug Enforcement Administration, Department of Justice